106 related articles for article (PubMed ID: 8986242)
1. Hepatocellular carcinoma associated with alcoholic liver disease: a clinicopathological study and genetic polymorphism of aldehyde dehydrogenase 2.
Ohhira M; Fujimoto Y; Matsumoto A; Ohtake T; Ono M; Kohgo Y
Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):378A-382A. PubMed ID: 8986242
[TBL] [Abstract][Full Text] [Related]
2. [A clinicopathological study of primary liver cancer associated with alcoholic liver injury].
Kohgo Y; Ohhira M; Ono M
Nihon Arukoru Yakubutsu Igakkai Zasshi; 1996 Apr; 31(2):155-63. PubMed ID: 8694740
[TBL] [Abstract][Full Text] [Related]
3. Aldehyde dehydrogenase 2 polymorphism for development to hepatocellular carcinoma in East Asian alcoholic liver cirrhosis.
Abe H; Aida Y; Seki N; Sugita T; Tomita Y; Nagano T; Itagaki M; Sutoh S; Nagatsuma K; Itoh K; Matsuura T; Aizawa Y
J Gastroenterol Hepatol; 2015 Sep; 30(9):1376-83. PubMed ID: 25778454
[TBL] [Abstract][Full Text] [Related]
4. Roles of alcohol, hepatitis virus infection, and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis.
Miyakawa H; Izumi N; Marumo F; Sato C
Alcohol Clin Exp Res; 1996 Feb; 20(1 Suppl):91A-94A. PubMed ID: 8659700
[TBL] [Abstract][Full Text] [Related]
5. The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis.
Saffroy R; Pham P; Chiappini F; Gross-Goupil M; Castera L; Azoulay D; Barrier A; Samuel D; Debuire B; Lemoine A
Carcinogenesis; 2004 Aug; 25(8):1443-8. PubMed ID: 15033905
[TBL] [Abstract][Full Text] [Related]
6. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease.
Nischalke HD; Lutz P; Krämer B; Söhne J; Müller T; Rosendahl J; Fischer J; Berg T; Hittatiya K; Fischer HP; Soyka M; Semmo N; Nattermann J; Sauerbruch T; Strassburg CP; Stickel F; Spengler U
J Hepatol; 2014 Nov; 61(5):1073-9. PubMed ID: 24946282
[TBL] [Abstract][Full Text] [Related]
7. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
[TBL] [Abstract][Full Text] [Related]
8. Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.
Charni F; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Trinchet JC; Beaugrand M; Charnaux N; Nahon P
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1439-46. PubMed ID: 21610221
[TBL] [Abstract][Full Text] [Related]
9. [Hepatocellular carcinoma: molecular biology aspects].
Blum HE
Zentralbl Chir; 1994; 119(11):759-63. PubMed ID: 7846955
[TBL] [Abstract][Full Text] [Related]
10. Studies on the incidence of hepatocellular carcinoma in heavy drinkers with liver cirrhosis.
Suzuki M; Suzuki H; Mizuno H; Tominaga T; Kono M; Kato Y; Sato A; Okabe K
Alcohol Alcohol Suppl; 1993; 1B():109-14. PubMed ID: 8003123
[TBL] [Abstract][Full Text] [Related]
11. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
12. Aldehyde dehydrogenase expression may be a prognostic biomarker and associated with liver cirrhosis in patients resected for hepatocellular carcinoma.
Pommergaard HC; Rasmussen A; Hillingsø J; Kugler JM
Surg Oncol; 2022 Mar; 40():101677. PubMed ID: 34896911
[TBL] [Abstract][Full Text] [Related]
13. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of small nodular lesions in heavy drinkers.
Suzuki M; Maeyama S; Nishikawa K; Okuse N; Hashizume K; Mamada Y; Kobayashi Y; Okuse C; Takahashi Y; Osada T; Hayashi T; Yotuyanagi H; Suzuki H; Ogata S; Uchikoshi T; Iino S
Alcohol Clin Exp Res; 2002 Aug; 26(8 Suppl):55S-62S. PubMed ID: 12198376
[TBL] [Abstract][Full Text] [Related]
15. Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study.
Yeh MM; Liu Y; Torbenson M
Hum Pathol; 2015 Nov; 46(11):1769-75. PubMed ID: 26410018
[TBL] [Abstract][Full Text] [Related]
16. National survey of hepatocellular carcinoma in heavy drinkers in Japan.
Horie Y; Yamagishi Y; Kajihara M; Kato S; Ishii H
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):32S-36S. PubMed ID: 12960504
[TBL] [Abstract][Full Text] [Related]
17. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption.
Fabris C; Toniutto P; Falleti E; Fontanini E; Cussigh A; Bitetto D; Fornasiere E; Fumolo E; Avellini C; Minisini R; Pirisi M
Alcohol Clin Exp Res; 2009 Jan; 33(1):102-7. PubMed ID: 18945219
[TBL] [Abstract][Full Text] [Related]
18. Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma--its relationship to alcohol drinking and the age of transfusion.
Noda K; Yoshihara H; Suzuki K; Yamada Y; Kasahara A; Hayashi N; Fusamoto H; Kamada T
Alcohol Clin Exp Res; 1996 Feb; 20(1 Suppl):95A-100A. PubMed ID: 8659701
[TBL] [Abstract][Full Text] [Related]
19. Chinese alcoholic patients with esophageal cancer are genetically different from alcoholics with acute pancreatitis and liver cirrhosis.
Chao YC; Wang LS; Hsieh TY; Chu CW; Chang FY; Chu HC
Am J Gastroenterol; 2000 Oct; 95(10):2958-64. PubMed ID: 11051375
[TBL] [Abstract][Full Text] [Related]
20. Etiologic influence on chromosomal aberrations in European hepatocellular carcinoma identified by CGH.
Homayounfar K; Schwarz A; Enders C; Cameron S; Baumhoer D; Ramadori G; Lorf T; Gunawan B; Sander B
Pathol Res Pract; 2013 Jun; 209(6):380-7. PubMed ID: 23706943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
